孤立性肌张力障碍的遗传风险因素全基因组关联研究

IF 7.4 1区 医学 Q1 CLINICAL NEUROLOGY Movement Disorders Pub Date : 2024-09-17 DOI:10.1002/mds.29968
Björn-Hergen Laabs PhD, Katja Lohmann PhD, Eva-Juliane Vollstedt MD, Tobias Reinberger PhD, Lisa-Marie Nuxoll MSc, Gamze Kilic-Berkmen PhD, Joel S. Perlmutter MD, Sebastian Loens MD, Carlos Cruchaga PhD, Andre Franke PhD, Valerija Dobricic PhD, Frauke Hinrichs, Anne Grözinger BSc, Eckart Altenmüller MD, Steven Bellows MD, Sylvia Boesch MD, MSc, Susan B. Bressman MD, Kevin R. Duque MD, Alberto J. Espay MD, Andreas Ferbert MD, Jeanne S. Feuerstein MD, Samuel Frank MD, Thomas Gasser MD, Bernhard Haslinger MD, Robert Jech MD, PhD, Frank Kaiser PhD, Christoph Kamm MD, Katja Kollewe MD, Andrea A. Kühn MD, Mark S. LeDoux MD, PhD, Ebba Lohmann MD, Abhimanyu Mahajan MD, MHS, Alexander Münchau MD, Trisha Multhaupt-Buell MS, CGC, Alexander Pantelyat MD, Sarah E. Pirio Richardson MD, Deborah Raymond MS, CGC, Stephen G. Reich MD, Rachel Saunders Pullman MD, MPH, MSc, Barbara Schormair PhD, Nutan Sharma MD, PhD, Azadeh Hamzehei Sichani MA, Kristina Simonyan MD, PhD, DrMed, Jens Volkmann MD, Aparna Wagle Shukla MD, Juliane Winkelmann MD, Laura J. Wright MA, Michael Zech MD, Kirsten E. Zeuner MD, Simone Zittel MD, Meike Kasten MD, Yan V. Sun PhD, Tobias Bäumer MD, Norbert Brüggemann MD, Laurie J. Ozelius PhD, Hyder A. Jinnah MD, PhD, Christine Klein MD, Inke R. König PhD
{"title":"孤立性肌张力障碍的遗传风险因素全基因组关联研究","authors":"Björn-Hergen Laabs PhD,&nbsp;Katja Lohmann PhD,&nbsp;Eva-Juliane Vollstedt MD,&nbsp;Tobias Reinberger PhD,&nbsp;Lisa-Marie Nuxoll MSc,&nbsp;Gamze Kilic-Berkmen PhD,&nbsp;Joel S. Perlmutter MD,&nbsp;Sebastian Loens MD,&nbsp;Carlos Cruchaga PhD,&nbsp;Andre Franke PhD,&nbsp;Valerija Dobricic PhD,&nbsp;Frauke Hinrichs,&nbsp;Anne Grözinger BSc,&nbsp;Eckart Altenmüller MD,&nbsp;Steven Bellows MD,&nbsp;Sylvia Boesch MD, MSc,&nbsp;Susan B. Bressman MD,&nbsp;Kevin R. Duque MD,&nbsp;Alberto J. Espay MD,&nbsp;Andreas Ferbert MD,&nbsp;Jeanne S. Feuerstein MD,&nbsp;Samuel Frank MD,&nbsp;Thomas Gasser MD,&nbsp;Bernhard Haslinger MD,&nbsp;Robert Jech MD, PhD,&nbsp;Frank Kaiser PhD,&nbsp;Christoph Kamm MD,&nbsp;Katja Kollewe MD,&nbsp;Andrea A. Kühn MD,&nbsp;Mark S. LeDoux MD, PhD,&nbsp;Ebba Lohmann MD,&nbsp;Abhimanyu Mahajan MD, MHS,&nbsp;Alexander Münchau MD,&nbsp;Trisha Multhaupt-Buell MS, CGC,&nbsp;Alexander Pantelyat MD,&nbsp;Sarah E. Pirio Richardson MD,&nbsp;Deborah Raymond MS, CGC,&nbsp;Stephen G. Reich MD,&nbsp;Rachel Saunders Pullman MD, MPH, MSc,&nbsp;Barbara Schormair PhD,&nbsp;Nutan Sharma MD, PhD,&nbsp;Azadeh Hamzehei Sichani MA,&nbsp;Kristina Simonyan MD, PhD, DrMed,&nbsp;Jens Volkmann MD,&nbsp;Aparna Wagle Shukla MD,&nbsp;Juliane Winkelmann MD,&nbsp;Laura J. Wright MA,&nbsp;Michael Zech MD,&nbsp;Kirsten E. Zeuner MD,&nbsp;Simone Zittel MD,&nbsp;Meike Kasten MD,&nbsp;Yan V. Sun PhD,&nbsp;Tobias Bäumer MD,&nbsp;Norbert Brüggemann MD,&nbsp;Laurie J. Ozelius PhD,&nbsp;Hyder A. Jinnah MD, PhD,&nbsp;Christine Klein MD,&nbsp;Inke R. König PhD","doi":"10.1002/mds.29968","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Despite considerable heritability, previous smaller genome-wide association studies (GWASs) have not identified any robust genetic risk factors for isolated dystonia.</p>\n </section>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>The objective of this study was to perform a large-scale GWAS in a well-characterized, multicenter sample of &gt;6000 individuals to identify genetic risk factors for isolated dystonia.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>Array-based GWASs were performed on autosomes for 4303 dystonia participants and 2362 healthy control subjects of European ancestry with subgroup analysis based on age at onset, affected body regions, and a newly developed clinical score. Another 736 individuals were used for validation.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>This GWAS identified no common genome-wide significant loci that could be replicated despite sufficient power to detect meaningful effects. Power analyses imply that the effects of individual variants are likely very small.</p>\n </section>\n \n <section>\n \n <h3> Conclusions</h3>\n \n <p>Moderate single-nucleotide polymorphism–based heritability indicates that common variants do not contribute to isolated dystonia in this cohort. Sequence-based GWASs (eg, by whole-genome sequencing) might help to better understand the genetic basis. © 2024 The Author(s). <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p>\n </section>\n </div>","PeriodicalId":213,"journal":{"name":"Movement Disorders","volume":"39 11","pages":"2110-2116"},"PeriodicalIF":7.4000,"publicationDate":"2024-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29968","citationCount":"0","resultStr":"{\"title\":\"Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies\",\"authors\":\"Björn-Hergen Laabs PhD,&nbsp;Katja Lohmann PhD,&nbsp;Eva-Juliane Vollstedt MD,&nbsp;Tobias Reinberger PhD,&nbsp;Lisa-Marie Nuxoll MSc,&nbsp;Gamze Kilic-Berkmen PhD,&nbsp;Joel S. Perlmutter MD,&nbsp;Sebastian Loens MD,&nbsp;Carlos Cruchaga PhD,&nbsp;Andre Franke PhD,&nbsp;Valerija Dobricic PhD,&nbsp;Frauke Hinrichs,&nbsp;Anne Grözinger BSc,&nbsp;Eckart Altenmüller MD,&nbsp;Steven Bellows MD,&nbsp;Sylvia Boesch MD, MSc,&nbsp;Susan B. Bressman MD,&nbsp;Kevin R. Duque MD,&nbsp;Alberto J. Espay MD,&nbsp;Andreas Ferbert MD,&nbsp;Jeanne S. Feuerstein MD,&nbsp;Samuel Frank MD,&nbsp;Thomas Gasser MD,&nbsp;Bernhard Haslinger MD,&nbsp;Robert Jech MD, PhD,&nbsp;Frank Kaiser PhD,&nbsp;Christoph Kamm MD,&nbsp;Katja Kollewe MD,&nbsp;Andrea A. Kühn MD,&nbsp;Mark S. LeDoux MD, PhD,&nbsp;Ebba Lohmann MD,&nbsp;Abhimanyu Mahajan MD, MHS,&nbsp;Alexander Münchau MD,&nbsp;Trisha Multhaupt-Buell MS, CGC,&nbsp;Alexander Pantelyat MD,&nbsp;Sarah E. Pirio Richardson MD,&nbsp;Deborah Raymond MS, CGC,&nbsp;Stephen G. Reich MD,&nbsp;Rachel Saunders Pullman MD, MPH, MSc,&nbsp;Barbara Schormair PhD,&nbsp;Nutan Sharma MD, PhD,&nbsp;Azadeh Hamzehei Sichani MA,&nbsp;Kristina Simonyan MD, PhD, DrMed,&nbsp;Jens Volkmann MD,&nbsp;Aparna Wagle Shukla MD,&nbsp;Juliane Winkelmann MD,&nbsp;Laura J. Wright MA,&nbsp;Michael Zech MD,&nbsp;Kirsten E. Zeuner MD,&nbsp;Simone Zittel MD,&nbsp;Meike Kasten MD,&nbsp;Yan V. Sun PhD,&nbsp;Tobias Bäumer MD,&nbsp;Norbert Brüggemann MD,&nbsp;Laurie J. Ozelius PhD,&nbsp;Hyder A. Jinnah MD, PhD,&nbsp;Christine Klein MD,&nbsp;Inke R. König PhD\",\"doi\":\"10.1002/mds.29968\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Despite considerable heritability, previous smaller genome-wide association studies (GWASs) have not identified any robust genetic risk factors for isolated dystonia.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>The objective of this study was to perform a large-scale GWAS in a well-characterized, multicenter sample of &gt;6000 individuals to identify genetic risk factors for isolated dystonia.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>Array-based GWASs were performed on autosomes for 4303 dystonia participants and 2362 healthy control subjects of European ancestry with subgroup analysis based on age at onset, affected body regions, and a newly developed clinical score. Another 736 individuals were used for validation.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>This GWAS identified no common genome-wide significant loci that could be replicated despite sufficient power to detect meaningful effects. Power analyses imply that the effects of individual variants are likely very small.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusions</h3>\\n \\n <p>Moderate single-nucleotide polymorphism–based heritability indicates that common variants do not contribute to isolated dystonia in this cohort. Sequence-based GWASs (eg, by whole-genome sequencing) might help to better understand the genetic basis. © 2024 The Author(s). <i>Movement Disorders</i> published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.</p>\\n </section>\\n </div>\",\"PeriodicalId\":213,\"journal\":{\"name\":\"Movement Disorders\",\"volume\":\"39 11\",\"pages\":\"2110-2116\"},\"PeriodicalIF\":7.4000,\"publicationDate\":\"2024-09-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/mds.29968\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Movement Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/mds.29968\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Movement Disorders","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/mds.29968","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景尽管具有相当大的遗传性,但之前的小型全基因组关联研究(GWAS)并未发现孤立性肌张力障碍的任何强有力的遗传风险因素。目的本研究的目的是在一个特征明确的、多中心的>6000人样本中进行大规模的GWAS,以确定孤立性肌张力障碍的遗传风险因素。方法对 4303 名肌张力障碍患者和 2362 名欧洲血统健康对照受试者的常染色体进行了基于芯片的 GWAS,并根据发病年龄、受影响的身体区域和新开发的临床评分进行了亚组分析。结果这项全球基因组研究没有发现可重复的全基因组显著位点,尽管有足够的力量检测有意义的效应。结论基于单核苷酸多态性的适度遗传性表明,常见变异不会导致该队列中的孤立性肌张力障碍。基于序列的全球基因组研究(如全基因组测序)可能有助于更好地了解其遗传基础。© 2024 The Author(s).运动障碍》由 Wiley Periodicals LLC 代表国际帕金森和运动障碍协会出版。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Genetic Risk Factors in Isolated Dystonia Escape Genome-Wide Association Studies

Background

Despite considerable heritability, previous smaller genome-wide association studies (GWASs) have not identified any robust genetic risk factors for isolated dystonia.

Objective

The objective of this study was to perform a large-scale GWAS in a well-characterized, multicenter sample of >6000 individuals to identify genetic risk factors for isolated dystonia.

Methods

Array-based GWASs were performed on autosomes for 4303 dystonia participants and 2362 healthy control subjects of European ancestry with subgroup analysis based on age at onset, affected body regions, and a newly developed clinical score. Another 736 individuals were used for validation.

Results

This GWAS identified no common genome-wide significant loci that could be replicated despite sufficient power to detect meaningful effects. Power analyses imply that the effects of individual variants are likely very small.

Conclusions

Moderate single-nucleotide polymorphism–based heritability indicates that common variants do not contribute to isolated dystonia in this cohort. Sequence-based GWASs (eg, by whole-genome sequencing) might help to better understand the genetic basis. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Movement Disorders
Movement Disorders 医学-临床神经学
CiteScore
13.30
自引率
8.10%
发文量
371
审稿时长
12 months
期刊介绍: Movement Disorders publishes a variety of content types including Reviews, Viewpoints, Full Length Articles, Historical Reports, Brief Reports, and Letters. The journal considers original manuscripts on topics related to the diagnosis, therapeutics, pharmacology, biochemistry, physiology, etiology, genetics, and epidemiology of movement disorders. Appropriate topics include Parkinsonism, Chorea, Tremors, Dystonia, Myoclonus, Tics, Tardive Dyskinesia, Spasticity, and Ataxia.
期刊最新文献
Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial. Omaveloxolone for the Treatment of Friedreich Ataxia: Efficacy, Safety, and Future Perspectives. Skin Inflammatory Reactions in Patients with Continuous Subcutaneous Injection of Foslevodopa-Foscarbidopa Hydrate: Histopathology. Stimulation-Evoked Resonant Neural Activity in the Subthalamic Nucleus Is Modulated by Sleep. 18F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1